Cargando…
Down-Regulation of Ribosomal S6 kinase RPS6KA6 in Acute Myeloid Leukemia Patients
OBJECTIVE: Signaling pathways such as extracellular regulated kinase/mitogen activated protein kinase (ERK/MAPK) have increased activity in leukemia. Ribosomal 6 kinase (RSK4) is a factor downstream of the MAPK/ERK pathway and an important tumor suppressor which inhibits ERK trafficking. Decrease in...
Autores principales: | Rafiee, Mohammad, Keramati, Mohammad Reza, Ayatollahi, Hosein, Sadeghian, Mohammad Hadi, Barzegar, Mohieddin, Asgharzadeh, Ali, Alinejad, Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988414/ https://www.ncbi.nlm.nih.gov/pubmed/27540520 |
Ejemplares similares
-
The ribosomal protein S6 kinase alpha-1 (RPS6KA1) induces resistance to venetoclax/azacitidine in acute myeloid leukemia
por: Weidenauer, Katharina, et al.
Publicado: (2023) -
Basic anatomy and tumor biology of the RPS6KA6 gene that encodes the p90 ribosomal S6 kinase-4
por: Sun, Yuan, et al.
Publicado: (2012) -
RPS6KA5 methylation predict response to 6-week treatment for adolescent MDD patients
por: Xu, Peiwei, et al.
Publicado: (2022) -
Lack of FLT3-TKD835 gene mutation in toxicity of sulfur mustard in Iranian veterans
por: Ayatollahi, Hossein, et al.
Publicado: (2015) -
FOXP2 regulates thyroid cancer cell proliferation and apoptosis via transcriptional activation of RPS6KA6
por: Yang, Feibiao, et al.
Publicado: (2022)